Previous studies have implied that myonuclei accumulation in a muscle is more important than myofibre number in the determination of muscle size in fetal/neonatal lambs. However, due to the lack of a reliable marker, the role of myogenic precursor nuclei (satellite cells) in myofibre hypertrophy in late fetal and postnatal life is not well understood. In this study, MyoD was shown to be a useful marker for actively proliferating satellite cells in both fetal and neonatal lambs. MyoD was used to determine whether there were differences in the number of actively proliferating satellite cells between single and twin fetuses/neonates, which may explain at least some of the difference in myofibre size observed near birth. Eighteen single-bearing and 9 twin-bearing Coopworth ewes were randomly assigned to one of three slaughter groups (100, 120 and 140 days of gestation). The remaining ewes were kept on pasture until 20 days postpartum at which time 4 single and 4 twin lambs were sacrificed. Twin fetuses/neonates had lower body weights and muscle weights compared to singles. Lower muscle weights in the twins were associated with smaller myofibre cross-sectional areas and lower total nuclei numbers and myogenic precursor cell numbers per muscle in selected hind-limb muscles. These results indicate that myofibre hypertrophy in late gestation and early postnatal life is related to myogenic precursor cell number which may have important implications for growth potential of the growth-restricted fetus.

1.
Allen, R.E., L.K. Boxhorn (1989) Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor I, and fibroblast growth factor. J Cell Physiol 138: 311–315.
2.
Allen, D.L., R.R. Roy, V.R. Edgerton (1999) Myonuclear domains in muscle adaptation and disease. Muscle Nerve 22: 1350–1360.
3.
Beermann, D.H., L.F. Hood, M. Liboff (1983) Satellite cell and myonuclei populations in rat soleus and extensor digitorum longus muscles after maternal nutritional deprivation and realimentation. J Anim Sci 57: 1618–1625.
4.
Buckingham, M. (1994) Muscle differentiation. Which myogenic factors make muscle? Curr Biol 1: 61–63.
5.
Buhlinger, C.A., P.J. Wangsness, R.J. Martin, J.H. Ziegler (1978) Body composition, in vitro lipid metabolism and skeletal muscle characteristics in fast-growing, lean and in slow-growing, obese pigs at equal weight and age. Growth 42: 225–236.
6.
Cooper, R.N., S. Tajbakhsh, V. Mouly, G. Cossu, M. Buckingham, G.S. Butler-Browne (1999) In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J Cell Sci 112: 2895–2901.
7.
Cornelison, D.D., B.J. Wold (1997) Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev Biol 191/2: 270–283.
8.
Denekamp, J., R.F. Kallman (1973) In vitro and in vivo labelling of animal tumours with tritiated thymidine. Cell Tissue Kinet 6: 217–227.
9.
Eftimie, R., H.R. Brenner, A. Buonanno (1991) Myogenin and MyoD join a family of skeletal muscle genes regulated by electrical activity. Proc Natl Acad Sci USA 88: 1349–1353.
10.
Ezekwe, M.O., R.J. Martin (1975) Cellular characteristics of skeletal muscles in selected strains of pigs and mice and the unselected control. Growth 39: 95–106.
11.
Feldman, J.L., F.E. Stockdale (1990) Skeletal muscle satellite cell diversity: Stellite cells form fibers of different types in cell culture. Dev Biol 143: 320–334.
12.
Florini, J.R., K.A. Magri (1989) Effects of growth factors on myogenic differentiation. Am J Physiol 256: C701–C711.
13.
Franzini-Armstrong, C., D.A. Fischman (1994) Morphogenesis of skeletal muscle fibres; in Engel, A.G., C. Franzini-Armstrong (eds): Myology, Basic and Clinical. New York, McGraw-Hill, pp 74–96.
14.
Gibson, M.C., E. Schultz (1982) The distribution of satellite cells and their relationships to specific fiber types in soleus and extensor digitorum longus muscles. Anat Rec 202: 329–337.
15.
Glore, S.R., D.K. Layman (1983a) Cellular development of skeletal muscle during early periods of nutritional restriction and subsequent rehabilitation. Pediatr Res 17: 602–605.
16.
Glore, S.R., D.K. Layman (1983b) Cellular growth of skeletal muscle in weanling rats during dietary restrictions. Growth 47: 403–410.
17.
Glore, S.R., D.K. Layman (1987) Cellular development of skeletal muscle of rats during recovery from prolonged undernutrition. J Nutr 227: 1767–1774.
18.
Greenwood, P.L., A.S. Hunt, J.W. Hermanson, A.W. Bell (2000) Effects of birth weight and postnatal nutrition on neonatal sheep. II. Skeletal muscle growth and development. J Anim Sci 78: 50–61.
19.
Gundersen, H.J.G., T.F. Bendtsen, L. Korbo, N. Marcussen, A. Moller, K. Nielsen, J.R. Myengaard, B. Pakkenberg, F.B. Sorensen, A. Vesterby, M.J. West (1988) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96: 379–394.
20.
Hartley, R.S., E. Bandman, Z. Yablonka-Reuveni (1992) Skeletal muscle satellite cells appear during late chicken embryogenesis. Dev Biol 153: 206–216.
21.
Hathaway, M.R., M.S. Pampusch, J.R. Hembree, W.R. Dayton (1994) Transforming growth factor beta-1 facilitates establishing clonal populations of ovine muscle satellite cells. J Anim Sci 72: 2001–2007.
22.
Hauschka, S.D. (1994) The embryonic origin of muscle; in Engel, A.G., C. Franzini-Armstrong (eds): Myology, Basic and Clinical. New York, McGraw-Hill, vol 1, pp 3–73.
23.
Howarth, R.E., R.I. Baldwin (1971) Synthesis and accumulation of protein and nucleic acid in rat gastrocnemius muscles during normal growth, restricted growth and recovery from restricted growth. J Nutr 101: 477–484.
24.
Hughes, S.M., K. Koishi, M. Rudnicki, A.M. Maggs (1997) MyoD protein is differentially accumulated in fast and slow skeletal muscle fibres and required for normal fibre type balance in rodents. Mech Dev 61: 151–163.
25.
Iatropoulos, M.J., G.M. Williams (1996) Proliferation markers. Exp Toxicol Pathol 48: 175–181.
26.
Kang, C.W., M.L. Sunde, R.W. Swick (1985) Characteristics of growth and protein turnover in skeletal muscle of turkey poults. Poult Sci 64: 380–387.
27.
Kaufmann, U., J. Kirsch, A. Irintchev, A. Wernig, A. Starzinski-Powitz (1999) The M-cadherin catenin complex interacts with microtubules in skeletal muscle cells: Implications for the fusion of myoblasts. J Cell Sci 112: 55–68.
28.
Kelly, A.M. (1978) Perisynaptic satellite cells in the developing and mature rat soleus muscle. Anat Rec 190: 891–904.
29.
Kitzmann, M., G. Carnac, M. Vandromme, M. Primig, N.J. Lamb, A. Fernandez (1998) The muscle regulatory factors MyoD and Myf-5 undergo distinct cell cycle-specific expression in muscle cells. J Cell Biol 142: 1447–1459.
30.
Koishi, K., M. Zhang, I.S. McLennan, A.J. Harris (1995) MyoD protein accumulates in satellite cells and is neurally regulated in regenerating myotubes and skeletal muscle fibres. Dev Dyn 202: 244–254.
31.
McCoard, S.A., S.W. Peterson, W.C. McNabb, P.M. Harris, S.N. McCutcheon (1997) Maternal constraint influences muscle fibre development in fetal lambs. Reprod Fertil Dev 9: 675–681.
32.
McCall, G.E., D.L. Allen, J.K. Linderman, R.E. Grindeland, R.R. Roy, V.R. Mukku, V.R. Edgerton (1998) Maintenance of myonuclear domain size in rat soleus after overload and growth hormone/IGF-I treatment. J Appl Physiol 84: 1407–1412.
33.
McPherron, A.C., A.M. Lawler, S.-J. Lee (1997) Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 387: 83–90.
34.
Mellor, D.J. (1983) Nutritional and placental determinants of foetal growth rate in sheep and consequences for the newborn lamb. Br Vet J 139: 307–324.
35.
Moss, F.P. (1968) The relationship between the dimensions of the fibers and the number of nuclei during normal growth of skeletal muscle in the domestic fowl. Am J Anat 122: 555–564.
36.
Moss, F.P., C.P. Leblond (1970) Satellite cells as the source of nuclei in muscles of growing rats. Anat Rec 170: 421–436.
37.
Nordby, D.J., R.A. Field, M.L. Riley, C.J. Kercher (1987) Effects of maternal undernutrition during early pregnancy on growth, muscle cellularity, fiber type and carcass composition in lambs. J Anim Sci 64: 1419–1427.
38.
Olson, E.N., W.H. Klein (1994) bHLH factors in muscle development: Dead lines and commitments, what to leave in and what to leave out. Genes Dev 8: 1–8.
39.
Powell, S.D., E.D. Aberle (1975) Cellular growth of skeletal muscle in swine differing in muscularity. J Anim Sci 40: 476–485.
40.
Purchas, R.W., D.R. Romsos, R.E. Allen, R.A. Merkel (1985) Muscle growth and satellite cell proliferative activity in obese (OB/OB) mice. J Anim Sci 60: 644–651.
41.
Robinson, D.W. (1969) The cellular response of porcine skeletal muscle to prenatal and neonatal nutritional stress. Growth 33: 231–240.
42.
Roy, R.R., S.R. Monke, D.L. Allen, V.R. Edgerton (1999) Modulation of myonuclear number in functionally overloaded and exercised rat plantaris fibers. J Appl Physiol 87: 634–642.
43.
Roy, R.R., D.I. Peirotti, V.R. Edgerton (1996) Skeletal muscle fiber cross-sectional area: Effects of freezing procedures. Acta Anat 155: 131–135.
44.
Rudnicki, M.A., T. Braun, S. Hinuma, R. Jaenisch (1992) Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 71: 383–390.
45.
Rudnicki, M.A., P.N. J. Schnegelsberg, R.H. Stead, T. Braun, H.H. Arnold, R. Jaenisch (1993) MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75: 1351–1359.
46.
Sassoon, D.A. (1993) Myogenic regulatory factors: Dissecting their role during vertebrate embryogenesis. Dev Biol 156: 11–23.
47.
Schultz, E., K.C. Darr, A. Macius (1994) Acute effects of hindlimb unweighting on satellite cells of growing skeletal muscle. J Appl Physiol 76/1: 266–270.
48.
Sika, M., D.K. Layman (1995) Food restriction and lysine supplementation alter growth, RNA, DNA, and protein contents of skeletal muscle. Growth Dev Aging 59: 15–23.
49.
Smith, J.H. (1963) Relation of body size to muscle cell size and number in the chicken. Poult Sci 42: 283–290.
50.
Snow, M.H. (1981) Satellite cell distribution within the soleus muscle of the adult mouse. Anat Rec 201: 463–469.
51.
Stockdale, F.E. (1992) Myogenic cell lineages. Dev Biol 154: 284–298.
52.
Swatland, H.J. (1984) Structure and Development of Meat Animals. Englewood Cliffs, Prentice-Hall.
53.
Weintraub, H. (1993) The MyoD family and myogenesis: Redundancy, networks, and thresholds. Cell 75: 1241–1244.
54.
Winick, M., A. Noble (1966) Cellular response in rats during malnutrition at various ages. J Nutr 89: 300–306.
55.
Witzemann, V., B. Sakmann (1991) Differential regulation of MyoD and myogenin messenger RNA levels by nerve induced muscle activity. FEBS Lett 282: 259–264.
56.
Yablonka-Reuveni, Z., M.A. Rudnicki, A.J. Rivera, M. Primig, J.E. Anderson, P. Natanson (1999) The transition from proliferation to differentiation is delayed in satellite cells from mice lacking MyoD. Dev Biol 210: 440–455.
57.
Zeschnigk, M., D. Kozian, C. Kuch, M. Schmoll, A. Starzinski-Powitz (1995) Involvement of M-cadherin in terminal differentiation of skeletal muscle cells. J Cell Sci 108: 2973–2981.
58.
Zhang, M., I.S. McLennan (1994) Use of antibodies to identify satellite cells with a light microscope. Muscle Nerve 17: 987–994.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.